Nitazoxanide, Drugs Monitor

(20 Apr 2021) Nitazoxanide- was associated with an 85% reduction in the progression to severe illness

April 30, 2021

Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization https://www.medrxiv.org/content/10.1101/2021.04.19.21255441v1 NCT04486313- Time to sustained response was not reduced by nitazoxanide (median: 13.28 and 12.35 days for nitazoxanide and placebo). Nitazoxanide treatment provided an 85% reduction… Continue reading "(20 Apr 2021) Nitazoxanide- was associated with an 85% reduction in the progression to severe illness"

(04 Mar 2021) Nitazoxanide- significant viral load reduction ≥ 35% from baseline up to day 7 of treatment

April 7, 2021

Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study https://www.medrxiv.org/content/10.1101/2021.03.03.21252509v1 NCT04463264- The objective of this study was to evaluate the efficacy and safety of Nitazoxanide in reducing the SARS-COV 2 viral… Continue reading "(04 Mar 2021) Nitazoxanide- significant viral load reduction ≥ 35% from baseline up to day 7 of treatment"

(17 Feb 2021) Nitazoxanide, Ivermectin, Ribavirin- plus Zinc effectively clear the SARS-COV2 from nasopharynx

February 19, 2021

Effect of a combination of Nitazoxanide, Ribavirin and Ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19 https://doi.org/10.1002/jmv.26880 NCT04392427- This non-randomized controlled trial included 62 patients on triple combination treatment versus 51 age- and sex-matched patients on… Continue reading "(17 Feb 2021) Nitazoxanide, Ivermectin, Ribavirin- plus Zinc effectively clear the SARS-COV2 from nasopharynx"

(29 Dec 2020) Nitazoxanide- early nitazoxanide therapy was safe and reduced viral load significantly

January 2, 2021

Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial https://doi.org/10.1183/13993003.03725-2020 NCT04552483- In a multicenter, randomised, double-blind, placebo-controlled trial, adult patients presenting up to 3 days after onset of Covid-19 symptoms (dry cough, fever, and/or fatigue) were enrolled. After… Continue reading "(29 Dec 2020) Nitazoxanide- early nitazoxanide therapy was safe and reduced viral load significantly"

(04 Nov 2020) Azithromycin, Nitazoxanide, Ivermectin and HCQ- AZT in combination with drugs proven beneficial

November 9, 2020

Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients https://www.medrxiv.org/content/10.1101/2020.10.31.20223883v1.full.pdf The objective of the present study (NCT04446429) was to elucidate whether the conduction of a full… Continue reading "(04 Nov 2020) Azithromycin, Nitazoxanide, Ivermectin and HCQ- AZT in combination with drugs proven beneficial"

Tag: Nitazoxanide

(20 Apr 2021) Nitazoxanide- was associated with an 85% reduction in the progression to severe illness

(04 Mar 2021) Nitazoxanide- significant viral load reduction ≥ 35% from baseline up to day 7 of treatment

(17 Feb 2021) Nitazoxanide, Ivermectin, Ribavirin- plus Zinc effectively clear the SARS-COV2 from nasopharynx

(29 Dec 2020) Nitazoxanide- early nitazoxanide therapy was safe and reduced viral load significantly

(04 Nov 2020) Azithromycin, Nitazoxanide, Ivermectin and HCQ- AZT in combination with drugs proven beneficial